Bin WANG

Bin WANG


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJin-Huan Wei
Jin-Huan Wei
AHAhmed Haddad
Ahmed Haddad
KWKai-Jie Wu
Kai-Jie Wu
HZHong-Wei Zhao
Hong-Wei Zhao
PKPayal Kapur
Payal Kapur
JLJunhang Luo
Junhang Luo
Clear cell renal cell carcinomas (ccRCCs) display divergent clinical behaviours. Molecular markers might improve risk stratification of ccRCC. Here we use, based on genome-wide CpG methylation profiling, a LASSO model to develop a five-CpG-based assay for ccRCC prognosis that can be used with formalin-fixed paraffin-embedded specimens. The five-CpG-based classifier was validated in three independent sets from China, United States and the Cancer Genome Atlas data set. The classifier predicts the overall survival of ccRCC patients (hazard ratio=2.96−4.82;P=3.9 × 10−6−2.2 × 10−9), independent of standard clinical prognostic factors. The five-CpG-based classifier successfully categorizes patients into high-risk and low-risk groups, with significant differences of clinical outcome in respective clinical stages and individual ‘stage, size, grade and necrosis’ scores. Moreover, methylation at the five CpGs correlates with expression of five genes:PITX1,FOXE3,TWF2,EHBP1L1andRIN1. Our five-CpG-based classifier is a practical and reliable prognostic tool for ccRCC that can add prognostic value to the staging system.

1 December 2013 in Cellular Signalling
Verified
Journal Article
Closed access
KWKaijie Wu
Kaijie Wu
ZNZhongyun Ning
Zhongyun Ning
JZJin Zeng
Jin Zeng
JFJinhai Fan
Jinhai Fan
JZJiancheng Zhou
Jiancheng Zhou
DHDalin He
Dalin He

1 January 2022 in International Journal of Biological Sciences
Verified
Journal Article
Open access
LZLizhe Zhu
Lizhe Zhu
QTQi Tian
Qi Tian
HGHuan Gao
Huan Gao
KWKaijie Wu
Kaijie Wu
BWBo Wang
Bo Wang
BWBin WANG
Bin WANG
Background: The progressive, multifactorial and multistep dynamic process of metastasis is the primary cause of breast cancer (BC) lethality. PROX1 (Prospero-related homeobox 1), as a type of transcription factor that plays a key role in the formation of lymphatic vessels in animal embryonic development, has been proven to promote or suppress cancer in a variety of malignant tumors. However, molecular mechanisms behind PROX1 induced breast cancer metastases remain elusive.

1 October 2018 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
BWBin WANG
Bin WANG
YGYanan Gu
Yanan Gu
KHKe Hui
Ke Hui
JHJun Huang
Jun Huang
SXShan Xu
Shan Xu
KWKaijie Wu
Kaijie Wu

15 June 2016 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AKAmit Kumar
Amit Kumar
TMTara Mastren
Tara Mastren
BWBin WANG
Bin WANG
JHJer-Tsong Hsieh
Jer-Tsong Hsieh
GHGuiyang Hao
Guiyang Hao
XSXiankai Sun
Xiankai Sun

9 February 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KHKe Hui
Ke Hui
YGYang Gao
Yang Gao
JHJun Huang
Jun Huang
SXShan Xu
Shan Xu
BWBin WANG
Bin WANG
KWKaijie Wu
Kaijie Wu
Muscle-invasive or metastatic bladder cancer (BCa) is associated with a very poor prognosis, and the underlying mechanism remains poorly understood. In this study, we demonstrate RASAL2, a RAS GTPase-activating protein (RAS GAP), acts as a tumor suppressor in BCa. First, RASAL2 was downregulated in BCa specimens and inversely correlated with pathological grades and clinical stages. Furthermore, we observed that RASAL2 could inhibit BCa stemness and epithelial–mesenchymal transition (EMT) based on our gain-of-function and loss-of-function experiments. Mechanistically, we found that mitogen-activated protein kinase/SOX2 signaling had a critical role for maintaining the stemness and mesenchymal properties of RASAL2-deficient BCa cells because inhibition of ERK activity or knockdown of SOX2 could reverse these phenotypes. Also, RASAL2 could inhibit BCa tumorigenesis and distant metastasis in vivo . Moreover, there was an inverse correlation between RASAL2 expression and the stemness/EMT status in subcutaneous xenograft and human BCa specimens. Taken together, our data indicate that RASAL2 is a tumor suppressor in BCa, and modulates cancer stemness and EMT for BCa recurrence and metastasis.